Comments
|
stock too risky, another drug company may, come from nowhere to outperform hep c drug VX-950
|
|
|
Tell me when this thread is updated: |
|
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
|
|
Apr '12 | Second round | 1 |
|
|
Feb '12 | David | 3 |
|
|
Feb '12 | Joanne Larsen | 1 |
|
|
Nov '11 | Gary | 1 |
|
|
Nov '10 | HCVnewdrugs | 1 |
|
|
May '09 | arrie weaver | 1 |
|
|
Apr '09 | Dave | 2 |